Cleared Traditional

K073471 - VANTAGECATH INTRAVASCULAR CATHETER

K073471 is an FDA 510(k) clearance for VANTAGECATH INTRAVASCULAR CATHETER, manufactured by Advantage Medical Device. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 141-day FDA review.

K073471 · Advantage Medical Device · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2008
Decision
141d
Days
Class 2
Risk

K073471 is an FDA 510(k) clearance for the VANTAGECATH INTRAVASCULAR CATHETER. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Advantage Medical Device (Laguna Niguel, US). The FDA issued a Cleared decision on April 30, 2008 after a review of 141 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Advantage Medical Device devices

FDA 510(k) Submission Details - K073471

510(k) Number K073471 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 11, 2007
Decision Date April 30, 2008
Days to Decision 141 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 129d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 356
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K073471.
SURSHIELD SAFETY I.V. CATHETER
K082362 · Terumo Medical Corp. · Sep 2008
COOK AND COOK SPECTRUM CENTRAL VENOUS CATHETERS
K081113 · Cook, Inc. · Jul 2008
SPECTRUM TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER
K081690 · Cook, Inc. · Jul 2008
MODIFICATION TO: LATEX-FREE BIONECTOR, MODEL# 896.019, 896.039
K070705 · Vygon Corp. · Nov 2007
ADVANTIV SAFETY I.V. CATHETER
K072419 · Smiths Medical Asd, Inc. · Nov 2007
ARROW, ARROWG+ARD AND ARROWG+ARD BLUE PLUS PRESSURE INJECTABLE CENTRAL VENOUS CATHETER
K071538 · Arrow International, Inc. · Aug 2007